病人自控静脉镇痛（PCIA）居家治疗难治性癌痛的可行性：一项回顾性分析

A retrospective analysis: Feasibility of patient controlled intravenous analgesia (PCIA) in the treatment of refractory cancer pain at home

摘要:

目的：回顾性分析病人自控静脉镇痛（PCIA）居家治疗难治性癌痛可行性。 方法：回顾性分析中国医科大学航空总医院安装PCIA治疗的癌痛患者37例，通过分析所有患者基本资料，镇痛效果、用药情况、药物不良反应、PCA泵安全性等指标，评估PCIA居家治疗难治性癌痛的可行性和安全性。 结果：PCIA居家镇痛总满意度为94.5%，患者在住院期间与居家治疗期间疼痛控制满意度无显著性差异。 结论：PCIA居家治疗难治性癌痛安全、可行，且居家镇痛将是难治性癌痛治疗的方向。

Abstract:

Objective: To retrospectively analyze the feasibility of patient-controlled intravenous analgesia (PCIA) in the treatment of refractory cancer pain at home. Methods: 37 patients with cancer pain treated with PCIA in the Aviation General Hospital of China Medical University were analyzed retrospectively. The feasibility and safety of PCIA in the treatment of refractory cancer pain at home were evaluated by analyzing the basic data of all patients, analgesic effect, medication, adverse drug reactions and the safety of PCA pump. Results: the total satisfaction of PCIA home analgesia was 94.5%. There was no significant difference between patients' satisfaction with pain control during hospitalization and home treatment. Conclusion: PCIA home treatment of refractory cancer pain is safe and feasible, and home analgesia will be the direction of refractory cancer pain treatment.